In 2023, a jury found that Medtronic infringed on a patent for a heart valve replacement method developed by Colibri Heart Valve.

A patient forum identified the desire for better, earlier education as well as the toll on independence TR takes as it ...

The recent decision by the US Centers for Medicare and Medicaid Services (CMS) to cover tricuspid transcatheter edge-to-edge ...

The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis ...

Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

The bicuspid aortic valve (BAV) is the most prevalent congen-ital heart defect and may require surgery for complications such as stenosis, regurgitation, and aortopathy. BAV repair surgery is ...

The final Medicare coverage memo for transcatheter edge-to-edge repair for tricuspid valve regurgitation largely replicates the April 2025 draft, but cardiology centers will not have to bring an ...

Background:The combination of selective percutaneous coronary intervention (PCI)and transcatheter aortic valve implantation (TAVI)is a safe and feasible therapy and has become our preferred treatment ...

Transcatheter Aortic Valve Reintervention: Long-Term Outcomes in an Asian Cohort Presenter: Jie Jun Wong ...

Evidence-based recommendations on transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. This involves implanting a replacement valve inside the faulty native valve ...

Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with aortic stenosis; however, the optimal postoperative anticoagulation therapy for patients with atrial fibrillation ...